High‐flow nasal cannulas versus standard oxygen therapy for moderate bronchiolitis: a quasi‐experimental analysis
It is crucial to perform additional RCTs with uniform protocols to determine the efficacy of HFNC more accurately in the treatment of bronchiolitis. HFNC does not reduce LOO, suggesting that early use of HFNC does not change the course of disease in moderate bronchiolitis. In view of the greater complexity and higher cost, HFNC should not be routinely used as first-line treatment in children with moderate respiratory distress and mild hypoxemia.
Authors
- Anna Chiara Vittucci (ORCID: https://orcid.org/0000-0002-1164-5563)
- Sebastian Cristaldi (ORCID: https://orcid.org/0000-0002-5648-1443)
- Andrea Dotta (ORCID: https://orcid.org/0000-0002-1260-6427)
- Renato Cutrera (ORCID: https://orcid.org/0000-0001-7711-5672)
- Alberto Villani (ORCID: https://orcid.org/0000-0002-9120-0424)
- Rossana Scutari (ORCID: https://orcid.org/0000-0001-8549-9645)
- Mara Pisani (ORCID: https://orcid.org/0000-0003-3779-8557)
- Lelia Rotondi Aufiero (ORCID: https://orcid.org/0000-0002-4117-8871)
- Carlo Federico Perno (ORCID: https://orcid.org/0000-0002-0825-5388)
- Chiara Velia Di Maio
- Livia Antilici (ORCID: https://orcid.org/0000-0003-0789-9779)
- Anna Maria Musolino (ORCID: https://orcid.org/0000-0001-9606-2860)
Institutions
- University of Rome Tor Vergata (IT)
- Bambino Gesù Children's Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1002/ppul.27358
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00